T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

NCT00008528 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

525

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Enfuvirtide

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]